Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001301348-08-000003
Filing Date
2008-03-28
Accepted
2008-03-27 17:42:22
Documents
6
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2007 hmbt_10-k12312007.htm 10-K 1144886
2 FORM OF SUBSCRIPTION AGREEMENT ex_10-19.htm EX-10.19 124147
3 FORM OF REGISTRATION RIGHTS AGREEMENT ex_10-20.htm EX-10.20 123120
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex_31-1.htm EX-31.1 15593
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER ex_31-2.htm EX-31.2 15377
6 SECTION 1350 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIA ex_32-1.htm EX-32.1 10360
  Complete submission text file 0001301348-08-000003.txt   1435047
Mailing Address 5001 SPRING VALLEY ROAD SUITE 1040 - WEST DALLAS TX 75244
Business Address 5001 SPRING VALLEY ROAD SUITE 1040 - WEST DALLAS TX 75244 972-455-8950
HEMOBIOTECH, INC. (Filer) CIK: 0001301348 (see all company filings)

EIN.: 330995817
Type: 10-K | Act: 34 | File No.: 000-51334 | Film No.: 08716112
SIC: 2836 Biological Products, (No Diagnostic Substances)